middle.news
Biome Australia Launches Major Clinical Trial for Proprietary Probiotic BMB18
8:28am on Tuesday 3rd of February, 2026 AEDT
•
Healthcare
Read Story
Biome Australia Launches Major Clinical Trial for Proprietary Probiotic BMB18
8:28am on Tuesday 3rd of February, 2026 AEDT
Key Points
Ethics approval granted by La Trobe University for BMB18 clinical trial
Randomised, double-blind, placebo-controlled study with 240 participants
Trial investigates effects on digestive symptoms, sleep, and mood disturbances
BMB18 is wholly owned IP, registered internationally, strengthening Biome’s competitive edge
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Biome Australia (ASX:BIO)
OPEN ARTICLE